Guidance

National measles guidelines

How to manage cases of suspected measles: what patient details to take, who to notify and assessing risk of disease spreading in close contacts.

From:
UK Health Security Agency
Published
28 October 2010
Last updated
25 July 2024 — See all updates

Applies to England

Documents

National measles guidelines

Ref: UKHSA publication gateway number GOV-16999

PDF, 939 KB, 60 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Measles warn and inform letter

Ref: UKHSA publication gateway number GOV-16113

ODT, 32.5 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Measles factsheet

HTML

Measles easy read warn and inform letter

PDF, 4.31 MB, 12 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Measles easy read factsheet

PDF, 3.11 MB, 10 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The national measles guidelines for health professionals covers:

  • how to decide if a suspected case of measles is ‘likely’ or ‘unlikely’
  • case management – what lab tests should be done and the importance of oral fluid testing on all suspected cases
  • measles control – identifying vulnerable contacts and assessing their need for post-exposure prophylaxis

As detailed in the guidance, the measles warn and inform letter can be used where it is necessary to contact a number of people who have been potentially exposed to a case of measles – please see the guidelines for further information about this.

The measles factsheet can be given to individuals to give them information about:

  • what measles is and how it spreads
  • symptoms and complications of measles
  • vaccination
  • what to do if you have measles

Translations of warn and inform letters

These translated warn and inform letters open as Word documents.

Translations of easy read warn and inform letters

These translated easy read warn and inform letters open as PDF documents.

Translations of factsheets

These translated factsheets open as PDF documents.

Updates to this page

Published 28 October 2010
Last updated 25 July 2024 + show all updates

  1. Guidance updated - see page 3 for change history.

  2. Added the translated easy read warn and inform letters.

  3. Added measles easy ready factsheet.

  4. Updated National measles guidelines - see page 3 for change history.

  5. Added the easy read warn and inform letter.

  6. Added translations of the warn and inform letters and factsheets.

  7. Clarification of responsibilities for risk assessment in healthcare settings page 37. Further product information added on immunoglobulin product, Cuvitru, page 35.

  8. Added factsheet and updated letter.

  9. Updated guidance see page 3 for change history.

  10. Updated guidance, including additional section on defining the time window for receiving post-exposure prophylaxis (PEP).

  11. Updated guidance.

  12. Added latest version of guidelines.

  13. Updated to reflect revised clinical advice.

  14. First published.

Sign up for emails or print this page

Related content